By Spondylitis Association of America
A new phase 3 clinical trial tested the efficacy and safety of the IL-17 inhibitor ixekizumab (brand name Taltz) in a population of ankylosing spondylitis (AS) patients who did not improve with TNF inhibitor (TNFi) treatment. Studies report that roughly 30 percent of those with AS don’t see enough improvement with their TNFi medications to continue treatment.
On October 20th, 2018 the Spondylitis Association of America hosted a free Spondylitis Educational Seminar in Chicago, IL. Our speakers for the day were Rheumatologist Dr. Muhammad Asim Khan, MD, MACP, FRCP and Registered Dietician Lara Rondinelli-Hamilton, RD, LDN, CDE.
Axial spondyloarthritis (axSpA) is a chronic rheumatic disease, which primarily affects the spine and other joints. It can be grouped into two types, radiographic (ankylosing spondylitis, AS) and non-radiographic (nr-axSpA.) Both types are associated with inflammatory pain and can involve functional impairment. As with many chronic conditions, depression is common among those living with axSpA; however the topic is not well studied, and reports of its prevalence vary greatly from study to study.
To give this topic more clarity, researchers conducted a systematic literature review, analyzing 16 international study findings...
Helpful Hints is a new recurring feature, aimed at sharing our community’s knowledge and experiences. In this first installment, we asked our community to share items, products, or tricks they find helpful for daily living with spondylitis issues. We share a sample of responses with our thanks. We hope you find them helpful!
This is a pre-clinical* research study with the goal of identifying biomarkers such as genetic, environmental, and microbial factors in the blood of adults with ankylosing spondylitis in order to determine what may influence the disease's development.
Visit our careers page for available positions
16360 Roscoe Blvd. Ste. 100Van Nuys, CA 91406
(800) 777-8189 U.S. only
or (818) 892-1616*Please note: This is not a Crisis Hotline. If you are in a life-threatening crisis, please dial 911 for immediate help in the US. Please follow this link for crisis intervention resources.